Why is MiniMax stock surging today?
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Zai Lab Ltd ADR (ZLAB)
Track today's live Zai Lab ADR (ZLAB) share price, performance and key data on this page with our current NASDAQ:ZLAB stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Zai Lab ADR share price on the NASDAQ exchange. Use the dropdown to switch exchange for the ZLAB share price, head to our technical summary section, which provides analysis on Zai Lab ADR share price buy/sell indicators using real-time data (or discuss the Zai Lab ADR (ZLAB) stock price today with other investors in the Zai Lab ADR NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ZLAB share price (ISIN: US98887Q1040) to enhance your trading decisions with our free investment tools and resources.
What Is the Zai Lab Ltd ADR Share Price Today?
The Zai Lab ADR share price today is 25.93.
What Is the Stock Symbol for Zai Lab Ltd ADR
The stock symbol (or 'ticker') for Zai Lab Ltd ADR is "ZLAB."
What Stock Exchange Does Zai Lab Ltd ADR Trade On?
Zai Lab Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Zai Lab Ltd ADR a Good Stock to Buy?
Determining whether Zai Lab ADR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current NASDAQ:ZLAB share price (ISIN: US98887Q1040) to enhance your trading decisions with our free investment tools and resources.
What Is the Zai Lab Ltd ADR Share Price Today?
The Zai Lab ADR share price today is 25.93.
What Is the Stock Symbol for Zai Lab Ltd ADR
The stock symbol (or 'ticker') for Zai Lab Ltd ADR is "ZLAB."
What Stock Exchange Does Zai Lab Ltd ADR Trade On?
Zai Lab Ltd ADR is listed and trades on the NASDAQ stock exchange.
Is Zai Lab Ltd ADR a Good Stock to Buy?
Determining whether Zai Lab ADR (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.37
26.22
52 wk Range
15.96
34.72
ZLAB is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
25.3726.22
52 wk Range
15.9634.72
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ZLAB Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
33.14
Upside
+27.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Zai Lab receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Why is MiniMax stock surging today?
- Investing.com
- Zai Lab receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 33.14
(+27.81% Upside)
Zai Lab Ltd ADR Earnings Call Summary for Q2/2026
- Zai Lab posted Q2 adjusted EPS of -$0.05, beating estimates of -$0.60 by 91.67%; revenue reached $106.3M vs. $104.34M forecast.
- Net product revenue rose 11% sequentially to $105.8M; company ended quarter with $717.5M cash and maintains commercial profitability.
- Management expects revenue stabilization in H2 2026 and meaningful growth in 2027, with first U.S. regulatory submission planned for 2027.
- Zoci ADC advances to global pivotal trials; Phase III data expected at ESMO October 2026 with ~60 patients, targeting 80% response rate.
- ZL-1503 first-in-human data due H2 2026; ZL-1311 IND submission targeted by year-end; operating expenses to remain stable through 2026.
Last Updated: 06/08/2026, 13:52
Read Full TranscriptEarnings
Latest Release
06/08/2026
EPS / Forecast
-0.05 / -0.60
Revenue / Forecast
106.3M / 104.34M
Compare ZLAB to Peers and Sector
Metrics to compare | ZLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipZLABPeersSector | |
|---|---|---|---|---|
P/E Ratio | −15.5x | −2.3x | −0.4x | |
PEG Ratio | −0.94 | −0.07 | 0.00 | |
Price/Book | 4.8x | 3.7x | 2.6x | |
Price / LTM Sales | 6.5x | 10.2x | 3.1x | |
Upside (Analyst Target) | 28.0% | 224.7% | 54.8% | |
Fair Value Upside | Unlock | 10.9% | 7.6% | Unlock |
Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Zai Lab ADR (NASDAQ: ZLAB) Share Price Today?
The Zai Lab ADR stock price today is 25.93 USD.
What Stock Exchange Does Zai Lab ADR (ZLAB) Trade On?
Zai Lab ADR is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Zai Lab ADR?
The stock symbol (also called a 'ticker') for Zai Lab ADR is "ZLAB."
What Is the Current Zai Lab ADR Market Capitalisation?
As of today, Zai Lab ADR (NASDAQ: ZLAB) market cap is 2.88B USD.
What Is Zai Lab ADR's (ZLAB) Earnings Per Share (TTM)?
The Zai Lab ADR EPS is currently -1.70 (Trailing Twelve Months).
When Is the Next Zai Lab ADR Earnings Date?
Zai Lab ADR's next earnings report will be released on 10/11/2026.
Is ZLAB a Buy or Sell From a Technical Analyst Perspective?
Based on today's Zai Lab ADR moving averages and other technical indicators, the daily buy/sell signal for ZLAB stock is Strong Buy.
How Many Times Has Zai Lab ADR Stock Split?
Zai Lab ADR has split 0 times. (See the ZLAB stock split history page for full effective split date and price information.)
How Many Employees Does Zai Lab ADR Have?
Zai Lab ADR has 1784 employees, based on their latest Companies House report.
What is the current trading status of Zai Lab ADR (NASDAQ: ZLAB)?
As of 30/09/2026, Zai Lab ADR (ZLAB) is trading at a share price of 25.93 USD, with a previous close of 25.93 USD. The stock has fluctuated within a day range of 25.37 USD to 26.22 USD, while its 52-week range spans from 15.96 USD to 34.72 USD.
What Is Zai Lab ADR (ZLAB) Price Target According to Analysts?
The average 12-month price target for Zai Lab ADR is 33.14 USD, with a high estimate of 50 USD and a low estimate of 24.25 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +27.81% Upside potential.
What Is the ZLAB Premarket Price?
ZLAB's last pre-market stock price is 25.53 USD. The pre-market share volume is 920.00, and the stock has decreased by -0.40, or -1.54%.
What Is the ZLAB After Hours Price?
ZLAB's last after hours stock price is 26.39 USD, the stock has decreased by 0.46, or 1.77%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.